FDA — authorised 2 June 2000
- Marketing authorisation holder: GENENTECH
- Status: approved
FDA authorised Tnkase on 2 June 2000
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Yes. FDA authorised it on 2 June 2000.
GENENTECH holds the US marketing authorisation.